Targeting HSP90 in breast cancer: Enchant-1 (NCT01677455) phase 2 proof of concept study of ganetespib in first-line treatment of women with metastatic breast cancer
Authors: Cameron, D.A., Spector, N., Cortes, J., Mano, M.S., Canon, J.-L.R., Hickish, T., Vandat, L.T., Kim, S.-B., Gomez, H.L., El-Hariry, I., Vukovic, V.M., Sheldon, E.H., Perez, E.A., Awada, A.
Journal: JOURNAL OF CLINICAL ONCOLOGY
Publication Date: 20/05/2014
Volume: 32
Issue: 15
eISSN: 1527-7755
ISSN: 0732-183X
DOI: 10.1200/jco.2014.32.15_suppl.tps665
Source: Web of Science